Buscar
01/01/2023
Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease
Fortea, J, Garcia-Arcelay, E, Terrancle, A, Galvez, B, Diez-Carreras, V, Rebollo, P, Maurino, J, Garcia-Ribas, G. Attitudes of Neurologists Toward the Use of Biomarkers in the Diagnosis of Early Alzheimer's Disease. JOURNAL OF ALZHEIMERS DISEASE. 2023; 93(1)DOI:10.3233/JAD-221160. PMID:36970902. IF:3.400(Q2/4D).
01/01/2023
The polygenic basis of relapse after a first episode of schizophrenia
Segura À.-G., Prohens L., Gassó P., Rodríguez N., Garcia-Rizo C., Moreno-Izco L., Andreu-Bernabeu Á., Zorrilla I., Mane A., Rodriguez-Jimenez R., Roldán A., Sarró S., Ibáñez Á., Usall J., Sáiz P.A., Cuesta M.J., Parellada M., González-Pinto A., Berrocoso E., Bernardo M., Mas S., Mezquida G., Arbelo N., De Matteis M., Galvañ J., Duque Guerra A., Arias i Queralt L., Perez-Bacigalupe M., Gonzalez-Ortega I., Toll A., Casanovas F., Sanchez-Pastor L., Valtueña M., Pomarol-Clotet E., García-León M.Á., Butjosa A., Rubio-Abadal E., Ribeiro M., López-Ilundain J.M., Saiz-Ruiz J., León-Quismondo L., Rivero O., Ruiz P., Echevarría R.S., García-Portilla M.P.. The polygenic basis of relapse after a first episode of schizophrenia. EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023; 75DOI:10.1016/j.euroneuro.2023.06.003. PMID:37603902. IF:(Q/D).
01/01/2023
Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study
González-Sánchez C., Salvador-Egea M.P., Glückmann-Maldonado E., Ríos A., Martín-Fernández J., Pérez-García J.I., García-Lorenzo F., Flores-Pastor B., Gómez-Ramírez J., Ortega-Serrano J., Ros-López S., Villar-del-Moral J., Morales-García D., Gutiérrez-Rodríguez M.T., Domènech-Calvet J., Nuño-Vázquez-Garza J.M., Franch-Arcas G.. Diagnosis and treatment of primary thyroid lymphoma from a surgical perspective: a multi-institutional study. LANGENBECKS ARCHIVES OF SURGERY. 2023; 408(1)DOI:10.1007/s00423-023-02945-x. PMID:37221304. IF:2.100(Q2/4D).
31/12/2022
GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases
Sala, R, Rioja-Blanco, E, Serna, N, Sanchez-Garcia, L, Alamo, P, Alba-Castellon, L, Casanova, I, Lopez-Pousa, A, Unzueta, U, Cespedes, MV, Vazquez, E, Villaverde, A, Mangues, R. GSDMD-dependent pyroptotic induction by a multivalent CXCR4-targeted nanotoxin blocks colorectal cancer metastases. DRUG DELIVERY. 2022; 29(1)DOI:10.1080/10717544.2022.2069302. PMID:35532120. IF:6.000(Q1/2D).